Worldwide orphan drug sales forecast to total $178bn in 2020
EvaluatePharma has just released their Orphan Drug Report 2015. This free report contains tons of great information on the current state of the market. A few highlights below: - Median cost per patient differential is 13.8 times higher for orphan drugs compared to non-orphan - Phase III orphan drug development costs half that of non-orphan but Phase III drug development - Worldwide orphan drug sales forecast to total $178bn (CAGR 2015 to 2020: +11.7%); nearly double the ove
AAD and the Dermatology Entrepreneurship Conference in San Francisco
We'll be at the Dermatology Entrepreneurship Conference on March 19 and at the American Academy of Dermatology's Annual Meeting from March 20 - 23. Both shows are in San Francisco. Please let us know if you would like to meet. #aad #dermatology #entrepreneurs #raredisease #orphandrugs #pharmaceuticals #sanfrancisco #healthcare #ichthyosis #biotech
Biotech Primer's Drug Development Immersion
Patagonia will attend Biotech Primer's Drug Development Immersion course in West Windsor, NJ from February 11-12. Please reach out to us if you would like to connect. #drugdevelopment #biotech #fda #orphandrugs #patagonia
